Delivery Order SPE2DB25D3022-SPE2DB25FWCFL
Award Date 8/12/25
Potential Completion Date 9/3/25
Potential Value $8.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,140.38 to AmerisourceBergen Drug Corp for ProQuad vials on August 11, 2025, with a completion date of September 2, 2025. This competitively awarded, firm fixed-price delivery order supports federal medical procurement needs and is being performed at the contractor's facility in Conshohocken, Pennsylvania. ProQuad is a combination vaccine providing immunity against measles, mumps, rubella, and varicella, making this order...
- The Defense Logistics Agency awarded a delivery order valued at $5,062.44 to AmerisourceBergen Drug Corp for ProQuad vials on August 18, 2025, with a completion date of September 9, 2025. This firm fixed price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. ProQuad is a combination vaccine protecting against measles, mumps, rubella, and varicella, commonly used within military and...
- The Defense Logistics Agency awarded a $3,374.96 delivery order to AmerisourceBergen Drug Corp for ProQuad vials on July 29, 2025, with an ultimate completion date of August 19, 2025. This firm fixed-price contract represents a non-set-aside competitive award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. ProQuad is a combination vaccine providing immunization protection against measles, mumps, rubella, and varicella, commonly used within military and federal...
- The Defense Logistics Agency awarded a $17,711.36 delivery order to AmerisourceBergen Drug Corp for ProQuad vials, with an ultimate completion date of August 25, 2025. This is a firm fixed-price, non-set-aside contract performed at the contractor's location in Conshohocken, Pennsylvania. ProQuad is a combination vaccine providing immunization against measles, mumps, rubella, and varicella, representing a critical pharmaceutical commodity within the federal medical supply chain. This delivery...
- The Defense Logistics Agency awarded a $49,629.90 firm fixed price delivery order to AmerisourceBergen Drug Corp for ProQuad vials, with an ultimate completion date of August 25, 2025. This is a competitively awarded, non-set-aside contract performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. ProQuad is a combination vaccine used for immunization against measles, mumps, rubella, and varicella, representing a critical pharmaceutical commodity for military and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ProQuad vials valued at $2,713.46, with an ultimate completion date of July 22, 2025. This firm fixed price delivery order represents a non-competitive set-aside contract and will be performed at the contractor's facility in Conshohocken, Pennsylvania. ProQuad is a combination vaccine used for immunization against measles, mumps, rubella, and varicella, reflecting the federal government's ongoing...
- The Defense Logistics Agency awarded a delivery order valued at $3,341.80 to AmerisourceBergen Drug Corp for ProQuad vials on August 15, 2025, with an ultimate completion date of September 8, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. ProQuad is a combination vaccine used to immunize against measles, mumps, rubella, and varicella, representing...
- The Defense Logistics Agency awarded a delivery order valued at $8,354.50 to AmerisourceBergen Drug Corp for ProQuad vials on August 27, 2025, with an ultimate completion date of September 18, 2025. This firm fixed price contract, which is not set-aside, is being performed at the contractor's facility in Conshohocken, Pennsylvania. ProQuad is a combination vaccine protecting against measles, mumps, rubella, and varicella, representing a critical pharmaceutical supply for military healthcare...
- The Defense Logistics Agency awarded a $13,367.20 delivery order to AmerisourceBergen Drug Corp for ProQuad vials on September 16, 2025, with an ultimate completion date of October 7, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. ProQuad is a combination vaccine used for immunization against measles, mumps, rubella, and varicella, representing a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for ProQuad vials, with a ceiling value of $9,908.95 and an ultimate completion date of August 28, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and will be performed in Conshohocken, Pennsylvania. ProQuad is a combination vaccine used for immunization against measles, mumps, rubella, and varicella, representing a critical...